Gurmeet Chadha from Complete Circle Consultants discusses the potential impact of the Biosecure Act on pharma and CDMO companies, rural spending boosts in FMCG due to Maharashtra elections, and the festive season. He also highlights market rotations towards IT, pharma, and FMCG sectors amid macroeconomic stability and upcoming rate cuts.
5 pharma stks with upside potential of up to 12%
Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to